sábado, 9 de agosto de 2014

Preventing Chronic Disease | Association Between Contraceptive Use and Gestational Diabetes: Missouri Pregnancy Risk Assessment Monitoring System, 2007–2008 - CDC

full-text ►

Preventing Chronic Disease | Association Between Contraceptive Use and Gestational Diabetes: Missouri Pregnancy Risk Assessment Monitoring System, 2007–2008 - CDC



Preventing Chronic Disease Logo



Association Between Contraceptive Use and Gestational Diabetes: Missouri Pregnancy Risk Assessment Monitoring System, 2007–2008

Brittney A. Kramer; Jeremy Kintzel, MA; Venkata Garikapaty, PhD

Suggested citation for this article: Kramer BA, Kintzel J, Garikapaty V. Association Between Contraceptive Use and Gestational Diabetes: Missouri Pregnancy Risk Assessment Monitoring System, 2007–2008. Prev Chronic Dis 2014;11:140059. DOI:http://dx.doi.org/10.5888/pcd11.140059External Web Site Icon.
PEER REVIEWED

Abstract

Introduction
The efficacy and safety of contraceptives have been questioned for decades; however, whether a relationship exists between hormonal contraceptives and gestational diabetes (GDM) is undetermined. The aim of this study was to investigate whether maternal risk for GDM was influenced by type of contraceptive method used before pregnancy.
Methods
Data collected in 2007 and 2008 by the Missouri Pregnancy Risk Assessment Monitoring System (PRAMS) were analyzed to determine if type of contraception before pregnancy influenced maternal risk for GDM. We used a logistic regression model to determine the adjusted odds for GDM given exposure to hormonal forms of contraception.
Results
Of the 2,741 women who completed the 2007–2008 PRAMS survey, 8.3% were diagnosed with gestational diabetes, and 17.9% of the respondents had used hormonal contraceptive methods. Women who used hormonal methods of birth control had higher odds for gestational diabetes (adjusted odds ratio [AOR] = 1.43; 95% confidence interval [CI], 1.32–1.55) than did women who used no contraception. A protective effect was also observed for women who had used barrier methods of contraception (AOR = 0.79; 95% CI, 0.72–0.86).
Conclusion
Findings suggest there may be a relationship between type of contraceptive method and GDM. More research is needed to verify contraception as a potential risk factor for GDM.

Acknowledgments

The authors thank Mary Mosley, Missouri state PRAMS coordinator, for hosting this research project and making the data available to the authors and Leigh Tenkku for encouragement and continual help and support. No financial support was received for the analysis or support of this article.

Author Information

Corresponding Author: Venkata Garikapaty, PhD, Missouri Department of Health and Senior Services, Office of Epidemiology, Maternal and Child Health, 920 Wildwood Dr, P.O. Box 570, Jefferson City, MO 65102. Telephone: 573-526-0452. E-mail: Venkata.Garikapaty@health.mo.gov.
Author Affiliations: Brittney A. Kramer, Jeremy Kintzel, Missouri Department of Health and Senior Services, Jefferson City, Missouri.

References

  1. Eschwege E, Fontbonne A, , Simon D, Thibult N, Balkau B, Saint-Paul M, et al. Oral contraceptives, insulin resistance and ischemic vascular disease. Int J Gynaecol Obstet 1990;31(3):263–9. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  2. Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990;323(20):1375–81. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  3. Russell-Briefel R, Ezzati TM, Perlman JA, Murphy RS. Impaired glucose tolerance in women using oral contraceptives: United States, 1976–1980. J Chronic Dis 1987;40(1):3–11. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  4. Kjos SL, Peters RK, Xiang A, Thomas D, Schaefer U, Buchanan TA. Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA 1998;280(6):533–8. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  5. Gestational Diabetes. American Diabetes Association. http://www.diabetes.org/are-you-at-risk/lower-your-risk/gdm.html. Accessed January 3, 2014.
  6. National diabetes statistics, 2011. National Diabetes Information Clearinghouse. http://diabetes.niddk.nih.gov/dm/pubs/statistics/#fast. Accessed January 16, 2014.
  7. Getahun D, Nath C, Ananth CV, Chavez MR, Smulian JC. Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol 2008;198(5):525–e1–5. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  8. Visser J, Snel M, Van Vliet HA. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2. Cochrane Database Syst Rev 2006;(4):CD003990. PubMedExternal Web Site Icon
  9. Diab KM, Zaki MM. Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A. J Obstet Gynaecol Res 2000;26(1):17–26. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  10. Di Cianni G, Volpe L, Lencioni C, Miccoli R, Cuccuru I, Ghio A, et al. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract 2003;62(2):131–7. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  11. Dornhorst A, Paterson CM, Nicholls JSD, Wadsworth J, Chiu DC, Elkeles RS, et al. High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med 1992;9(9):820–5. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  12. Diseases and conditions: risk factors: gestational diabetes. Mayo Clinic. http://www.mayoclinic.org/diseases-conditions/gestational-diabetes/basics/risk-factors/con-2001485413. Accessed January 3, 2014.
  13. Alexander GR, Cornely DA. Prenatal care utilization: its measurement and relationship to pregnancy outcome. Am J Prev Med 1987;3(5):243–53.PubMedExternal Web Site Icon
  14. Griffin JF, Hogan JW, Buechner JS, Leddy TM. The effect of a Medicaid managed care program on the adequacy of prenatal care utilization in Rhode Island. Am J Public Health 1999;89(4):497–501. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  15. Delgado-Rodríguez M, Gómez-Olmedo M, Bueno-Cavanillas A, Gálvez-Vargas R. Unplanned pregnancy as a major determinant in inadequate use of prenatal care. Prev Med 1997;26(6):834–8. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  16. Burke CW. The effect of oral contraceptives on cortisol metabolism. J Clin Pathol 1969;1(1):11–8. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  17. Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci 1999;96:513–23. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon

No hay comentarios: